niacinamide has been researched along with Actinic Keratosis in 25 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These data suggest that there could be an association between sorafenib therapy and the development of cutaneous SCC and inflammation of AK." | 7.75 | Cutaneous squamous cell carcinoma and inflammation of actinic keratoses associated with sorafenib. ( Dubauskas, Z; Hwu, P; Jonasch, E; Kunishige, J; Prieto, VG; Tannir, NM, 2009) |
| "These data suggest that there could be an association between sorafenib therapy and the development of cutaneous SCC and inflammation of AK." | 3.75 | Cutaneous squamous cell carcinoma and inflammation of actinic keratoses associated with sorafenib. ( Dubauskas, Z; Hwu, P; Jonasch, E; Kunishige, J; Prieto, VG; Tannir, NM, 2009) |
| "The dosage was reduced from 1000 to 500 mg due to gastrointestinal symptoms in the run-in phase." | 3.30 | Oral Nicotinamide for Actinic Keratosis Prevention in Kidney Transplant Recipients: A Pilot Double-Blind, Randomized, Placebo-Controlled Trial. ( Bostom, A; Cho, E; George-Washburn, EA; Gohh, R; Hashemi, KB; Robinson-Bostom, L; Walker, J; Weinstock, MA; Zhang, H, 2023) |
| "Nonmelanoma skin cancers, such as basal-cell carcinoma and squamous-cell carcinoma, are common cancers that are caused principally by ultraviolet (UV) radiation." | 2.80 | A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention. ( Chen, AC; Chinniah, N; Choy, B; Dalziell, RA; Damian, DL; Dhillon, HM; Fernández-Peñas, P; Halliday, GM; Kricker, A; Martin, AJ; McKenzie, CA; Scolyer, RA; St George, G; Vardy, JL, 2015) |
| "Actinic keratosis is one of the most common skin diseases." | 2.55 | [New approaches for the prevention of actinic keratosis]. ( Krutmann, J; Stege, H, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.00) | 29.6817 |
| 2010's | 18 (72.00) | 24.3611 |
| 2020's | 6 (24.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hunt, SV | 1 |
| Jamison, A | 1 |
| Malhotra, R | 1 |
| Allen, NC | 1 |
| Martin, AJ | 4 |
| Snaidr, VA | 2 |
| Eggins, R | 1 |
| Chong, AH | 1 |
| Fernandéz-Peñas, P | 3 |
| Gin, D | 1 |
| Sidhu, S | 1 |
| Paddon, VL | 1 |
| Banney, LA | 1 |
| Lim, A | 1 |
| Upjohn, E | 1 |
| Schaider, H | 1 |
| Ganhewa, AD | 1 |
| Nguyen, J | 1 |
| McKenzie, CA | 2 |
| Prakash, S | 1 |
| McLean, C | 1 |
| Lochhead, A | 1 |
| Ibbetson, J | 1 |
| Dettrick, A | 1 |
| Landgren, A | 1 |
| Allnutt, KJ | 1 |
| Allison, C | 1 |
| Davenport, RB | 1 |
| Mumford, BP | 1 |
| Wong, B | 1 |
| Stagg, B | 1 |
| Tedman, A | 1 |
| Gribbin, H | 1 |
| Edwards, HA | 1 |
| De Rosa, N | 1 |
| Stewart, T | 1 |
| Doolan, BJ | 1 |
| Kok, Y | 1 |
| Simpson, K | 1 |
| Low, ZM | 1 |
| Kovitwanichkanont, T | 1 |
| Scolyer, RA | 2 |
| Dhillon, HM | 2 |
| Vardy, JL | 2 |
| Chadban, SJ | 1 |
| Bowen, DG | 1 |
| Chen, AC | 4 |
| Damian, DL | 8 |
| Zhang, H | 1 |
| George-Washburn, EA | 1 |
| Hashemi, KB | 1 |
| Cho, E | 1 |
| Walker, J | 1 |
| Weinstock, MA | 1 |
| Bostom, A | 1 |
| Robinson-Bostom, L | 1 |
| Gohh, R | 1 |
| Paugam, C | 2 |
| Dréno, B | 2 |
| Tee, LY | 1 |
| Sultana, R | 1 |
| Tam, SYC | 1 |
| Oh, CC | 1 |
| Arzeno, J | 1 |
| Leavitt, E | 1 |
| Lonowski, S | 1 |
| Kim, J | 1 |
| Stege, H | 1 |
| Krutmann, J | 1 |
| Drago, F | 2 |
| Ciccarese, G | 2 |
| Cogorno, L | 1 |
| Calvi, C | 1 |
| Marsano, LA | 1 |
| Parodi, A | 2 |
| Arenberger, P | 1 |
| Arenbergerova, M | 1 |
| Nestor, L | 1 |
| Clowry, J | 1 |
| Molloy, K | 1 |
| Connolly, M | 1 |
| Salim, A | 1 |
| Tobin, AM | 1 |
| Halliday, GM | 4 |
| Kim, B | 1 |
| Choy, B | 1 |
| Dalziell, RA | 1 |
| Kricker, A | 1 |
| St George, G | 1 |
| Chinniah, N | 1 |
| Sidaway, P | 1 |
| Hajdenberg, J | 1 |
| Zhao, Y | 1 |
| Escudero-Góngora, MM | 1 |
| Dubauskas, Z | 1 |
| Kunishige, J | 1 |
| Prieto, VG | 1 |
| Jonasch, E | 1 |
| Hwu, P | 1 |
| Tannir, NM | 1 |
| Moloney, F | 1 |
| Vestergaard, M | 1 |
| Radojkovic, B | 1 |
| Damian, D | 1 |
| Surjana, D | 1 |
| Moloney, FJ | 1 |
8 reviews available for niacinamide and Actinic Keratosis
| Article | Year |
|---|---|
Oral nicotinamide for non-melanoma skin cancers: A review.
Topics: Humans; Keratosis, Actinic; Niacinamide; Research Design; Skin Neoplasms | 2023 |
Chemoprevention of keratinocyte carcinoma and actinic keratosis in solid-organ transplant recipients: Systematic review and meta-analyses.
Topics: Acitretin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Humans; Keratosis, Actinic; Niacinamide; | 2021 |
Nicotinamide for skin cancer chemoprevention.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; DNA Repair; Humans; Immune Tolerance; Keratosis, Ac | 2017 |
[New approaches for the prevention of actinic keratosis].
Topics: Antioxidants; Dermatology; Evidence-Based Medicine; Humans; Keratosis, Actinic; Niacinamide; Radiati | 2017 |
New and current preventive treatment options in actinic keratosis.
Topics: Carcinoma, Squamous Cell; Disease Progression; Female; Humans; Keratosis, Actinic; Male; Niacinamide | 2017 |
Nicotinamide for photoprotection and skin cancer chemoprevention: A review of efficacy and safety.
Topics: Adenosine Triphosphate; Animals; Anti-Inflammatory Agents; Chemoprevention; Dermatology; DNA Damage; | 2019 |
Nicotinamide and the skin.
Topics: Acne Vulgaris; Animals; Autoimmune Diseases; Carcinogenesis; Dermatitis, Atopic; Humans; Keratosis, | 2014 |
Nicotinamide: New Indications in Dermatology.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chemoprevention; Clinical Trials, Phase III as Topi | 2016 |
7 trials available for niacinamide and Actinic Keratosis
| Article | Year |
|---|---|
Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients.
Topics: Antineoplastic Agents; Australia; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chemoprevention; | 2023 |
Oral Nicotinamide for Actinic Keratosis Prevention in Kidney Transplant Recipients: A Pilot Double-Blind, Randomized, Placebo-Controlled Trial.
Topics: Double-Blind Method; Humans; Keratosis, Actinic; Kidney Transplantation; Niacinamide; Skin; Treatmen | 2023 |
Prevention of non-melanoma skin cancers with nicotinamide in transplant recipients: a case-control study.
Topics: Carcinoma, Squamous Cell; Case-Control Studies; Female; Humans; Keratosis, Actinic; Kidney Transplan | 2017 |
Nicotinamide for prevention of nonmelanoma skin cancers: a change in practice?
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cost of Illness; Humans; Keratosis, Actinic; Niacin | 2017 |
A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Double-Blind Method | 2015 |
Randomized, double-blinded, placebo controlled study to assess the effect of topical 1% nicotinamide on actinic keratoses.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Follow-Up Studies; Humans; Keratosis, Actinic; | 2010 |
Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials.
Topics: Aged; Aged, 80 and over; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Transformation, Neopl | 2012 |
10 other studies available for niacinamide and Actinic Keratosis
| Article | Year |
|---|---|
Is nicotinamide a sustainable therapy for resistant actinic keratoses?
Topics: Humans; Keratosis, Actinic; Niacinamide; Skin Neoplasms | 2020 |
Current Practices for Preventative Interventions for Nonmelanoma Skin Cancers Among Dermatologic Surgeons.
Topics: Acitretin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dermatologic Agents; Humans; Institution | 2021 |
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cryotherapy; Dermatologic Agents; Fl | 2019 |
Oral nicotinamide and actinic keratosis: a supplement success story.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Dietary Supplements; DNA Repair; Humans; Immun | 2015 |
Skin cancer: Nicotinamide reduces new skin cancer risk.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Humans; Keratosis, Actinic; Male; Niacinami | 2016 |
ACP Journal Club. In high-risk patients, oral nicotinamide reduced number of new nonmelanoma skin cancers during treatment.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Humans; Keratosis, Actinic; Male; Niacinami | 2016 |
Nicotinamide for Skin-Cancer Chemoprevention.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Humans; Keratosis, Actinic; Male; Niacinami | 2016 |
Nicotinamide for Skin-Cancer Chemoprevention.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Humans; Keratosis, Actinic; Male; Niacinami | 2016 |
Nicotinamide for Skin-Cancer Chemoprevention.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Humans; Keratosis, Actinic; Male; Niacinami | 2016 |
Cutaneous squamous cell carcinoma and inflammation of actinic keratoses associated with sorafenib.
Topics: Aged; Benzenesulfonates; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Drug Eruptions; Female; Hu | 2009 |